Comprehensive Analysis of MRSA Peptides Via Maldi

Year : 2024 | Volume :15 | Issue : 02 | Page : 98-101
By

Akshita Gupta,

Rekha Karwasra,

  1. Research Scholar Department of Basics and Applied Sciences, Nirwan University Jaipur Rajasthan India
  2. Professor Department of Basics and Applied Sciences, Nirwan University Jaipur Rajasthan India

Abstract

This study employs Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry to analyze MRSA peptides, focusing on various parameters associated with mass-to-charge (m/z) values. Through systematic data collection and analysis, including time, intensity, signal-to-noise ratios (SN), quality factors, resolutions, areas under the peaks, relative intensities, full widths at half maximum (FWHM), chi-squared values, and background peaks, comprehensive insights into the spectral characteristics of MRSA peptides are obtained. Methicillin-resistant Staphylococcus aureus (MRSA) is a major public health concern due to its resistance to commonly used antibiotics and its ability to cause severe infections. This study provides a comprehensive analysis of MRSA peptides using Matrix-Assisted Laser Desorption/Ionization (MALDI) mass spectrometry to identify potential biomarkers and therapeutic targets. MRSA isolates were collected from clinical samples obtained from patients in a tertiary care hospital over a six-month period. The isolates were cultured and subjected to protein extraction procedures. Peptide profiles were generated using MALDI mass spectrometry, and the resulting spectra were analyzed to identify specific peptides associated with MRSA. The analysis revealed a distinct peptide signature unique to MRSA isolates, differentiating them from methicillin-sensitive Staphylococcus aureus (MSSA) and other bacterial strains. Several peptides were identified as potential biomarkers for MRSA, including those involved in antibiotic resistance, virulence, and biofilm formation. Notably, peptides related to the mecA gene, responsible for methicillin resistance, were consistently detected in MRSA isolates. Additionally, comparative analysis of peptide profiles from different MRSA strains highlighted variations in protein expression related to geographic and clinical sources, providing insights into the epidemiology and evolution of MRSA.

Keywords: MRSA, peptides, MALDI-TOF, mass spectrometry, antibiotic resistance.

[This article belongs to Research & Reviews: A Journal of Pharmaceutical Science(rrjops)]

How to cite this article: Akshita Gupta, Rekha Karwasra. Comprehensive Analysis of MRSA Peptides Via Maldi. Research & Reviews: A Journal of Pharmaceutical Science. 2024; 15(02):98-101.
How to cite this URL: Akshita Gupta, Rekha Karwasra. Comprehensive Analysis of MRSA Peptides Via Maldi. Research & Reviews: A Journal of Pharmaceutical Science. 2024; 15(02):98-101. Available from: https://journals.stmjournals.com/rrjops/article=2024/view=156476



References

1. Chand, W, Neeraj, G, Oberoi, JK, Reena, R, Datta, S & Prasad, KJ 2010, ‘Surveillance of Multidrug Resistant Organisms in a Tertiary Care Hospital in Delhi,India’, vol. 58, pp. 50.

2. Chatterjee, SS, Ray, P, Aggarwal, A, Das A, Sharma, MA 2009, ‘Community-based study on nasal carriage of Staphylococcus aureus’,IndianJournalofMedicalResearch,vol. 130, no. 6, pp. 742–748.

3. Cheesbrough M, 2009, ‘District Laboratory Practice in Tropical Countries’, Cambridge university UK, vol. 2, no. 2, pp. 65–67. 4. Cheesbrough, M 2002, ‘District laboratory practice in tropical countries’, Cambridge University Press UK, pp. 136–142.

5. Claydon, MA, Davey, SN, Edwards-Jones, V & Gordon, DB 1996, ‘The rapid identification of intact microorganisms using mass spectrometry’, Journal of Nature Biotechnology, vol. 14, pp.1584–1586.

6. Clinical and Laboratory Standards Institute (CLSI) 2012, ‘Laboratory Methods for Detection of Methicillin-Resistant Staphylococcus aureus (MRSA)’, vol. M100-S22, pp. 88–90.

7. Collee, JG & Marr, W, Culture of bacteria. In: Collee JG, Fraser AG, Marmion BP, Mackie & McCartney 2006, ‘Practical medical microbiology’, 14th edn. Churchill Livingstone: New Delhi, pp. 113–29.

8. Collee, JG, Fraser, AG, Marmion, BP & Simmons, A, Mackie & McCartney 1996, ‘Practical Medical Microbiology’, 14th ed. Vol. 2. Churchill Livingstone: London, pp. 245–261.

9. Collins, CJ & O’Connell, B 2012, ‘Infectious disease outbreaks in competitive sports’, 2005-2010. Journal of Athletic Training, vol. 47, no. 5, pp. 516–518.

10. Concepcion Porrero, M, Ewan Harrison, Jose Francisco FernandezGarayzabal, Gavin Paterson, K, Alberto Diez-Guerrier, Mark Holmes, A& Lucas Domíngu 2014, ‘Detection of mecC-Methicillin-resistant Staphylococcus aureus isolates in river water: a potential role for water in the environmental dissemination’, Environmental microbiology reports, vol. 6, no. 6, pp. 705–708.

11. Cox, RA, Conquest, C, Mallaghan, C & Marples, RR 1995, ‘A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16)’, Journal of Hospital Infectious, vol. 29, no. 2, pp. 87–106.

12. Daskalaki, M, Rojo, P, Marin, F, Barrios, M, Otero, R & Chaves, F 2009, ‘Panton Valentine Leucocidin positive Staphylococcus aureus skin and soft tissue infectios among children in emergency department in Madrid Spain’, European society of clinical microbiology and infectious diseases, vol. 10, pp. 469–484.

13. Deresinski, S 2005, ‘Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic and therapeutic odyssey’, Clinical Infectious Diseases, vol. 40, pp. 562–573.

14. Deurenberg, RH, Vink, C, Kalenic, S, Friedrich, AW, Bruggeman, CA & Stobberingh, EE 2007, ‘The molecular evolution of methicillinresistant Staphylococcus aureus’, Clinical Microbiology Infectious, vol. 13, no. 3, pp. 222–235.

15. Diep, BA, Carleton, HA, Chang, RF, Sensabaugh, GF &Remington, FP 2006, ‘Roles of virulence genes in the evolution of hospital and community-associated strains of methicillin-resistant staphylococcus aureus’, The Journal of Infectious Diseases, vol. 193, pp. 1495–1503

16. Parvizi, J., and Azzam, K. (2009) Microbiological, Clinical, and Surgical Features of Fungal Prosthetic Joint Infections: A Multi-Institutional Experience. The Journal of Bone & Joint Surgery 91(Supplement_6):p 142–149, November 01, 2009. | DOI: 10.2106/JBJS.I.00574

17. Boswihi SS, Udo EE. Methicillin-resistant Staphylococcus aureus: An update on the epidemiology, treatment options and infection control. Current Medicine Research and Practice. 2018 Jan 1;8(1):18–24.


Regular Issue Subscription Review Article
Volume 15
Issue 02
Received June 6, 2024
Accepted July 3, 2024
Published July 16, 2024